Patents by Inventor Ulrich Wetterauer

Ulrich Wetterauer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
    Patent number: 9238694
    Abstract: Isolated monoclonal antibodies or an antigen binding portion thereof which bind to prostate specific membrane antigen in its native form occurring on the surface of tumor cells characterized in that it is linked to a label or a cytotoxic agent or constructed as a part of a bispecific antibody or a recombinant diabody.
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: January 19, 2016
    Assignee: UNIVERSITÄTSKLINIKUM FREIBURG
    Inventors: Ursula Elsässer-Beile, Philipp Wolf, Dorothee Gierschner, Patrick Bühler, Ulrich Wetterauer
  • MONOCLONAL ANTIBODIES AND SINGLE CHAIN ANTIBODY FRAGMENTS AGAINST CELL-SURFACE PROSTATE SPECIFIC MEMBRANE ANTIGEN
    Publication number: 20140155583
    Abstract: Isolated monoclonal antibodies or an antigen binding portion thereof which bind to prostate specific membrane antigen in its native form occurring on the surface of tumor cells characterized in that it is linked to a label or a cytotoxic agent or constructed as a part of a bispecific antibody or a recombinant diabody.
    Type: Application
    Filed: December 13, 2013
    Publication date: June 5, 2014
    Applicant: UNIVERSITÄTSKLINIKUM FREIBURG
    Inventors: Ursula Elsässer-Beile, Philipp Wolf, Dorothee Gierschner, Patrick Bühler, Ulrich Wetterauer
  • Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen as diagnostic and therapeutic tools for prostate cancer
    Patent number: 8632777
    Abstract: Isolated monoclonal antibodies or an antigen binding portion thereof which bind to prostate specific membrane antigen in its native form occurring on the surface of tumor cells characterized in that it is linked to a label or a cytotoxic agent or constructed as a part of a bispecific antibody or a recombinant diabody.
    Type: Grant
    Filed: May 8, 2012
    Date of Patent: January 21, 2014
    Assignee: Universitätsklinikum Freiburg
    Inventors: Ursula Elsässer-Beile, Philipp Wolf, Dorothee Gierschner, Patrick Bühler, Ulrich Wetterauer
  • MONOCLONAL ANTIBODIES AND SINGLE CHAIN ANTIBODY FRAGMENTS AGAINST CELL-SURFACE PROSTATE SPECIFIC MEMBRANE ANTIGEN AS DIAGNOSTIC AND THERAPEUTIC TOOLS FOR PROSTATE CANCER
    Publication number: 20120231024
    Abstract: Isolated monoclonal antibodies or an antigen binding portion thereof which bind to prostate specific membrane antigen in its native form occurring on the surface of tumor cells characterized in that it is linked to a label or a cytotoxic agent or constructed as a part of a bispecific antibody or a recombinant diabody.
    Type: Application
    Filed: May 8, 2012
    Publication date: September 13, 2012
    Inventors: Ursula Elsässer-Beile, Philipp Wolf, Dorothee Gierschner, Patrick Bühler, Ulrich Wetterauer
  • Monoclonal antibodies and single chain antibody fragments against cell-surface prostate specific membrane antigen
    Patent number: 8198416
    Abstract: Isolated monoclonal antibodies or an antigen binding portion thereof which bind to prostate specific membrane antigen in its native form occurring on the surface of tumor cells characterized in that it is linked to a label or a cytotoxic agent or constructed as a part of a bispecific antibody or a recombinant diabody.
    Type: Grant
    Filed: March 2, 2006
    Date of Patent: June 12, 2012
    Assignee: Universitaetsklinikum Freiburg
    Inventors: Ursula Elsässer-Beile, Philipp Wolf, Dorothee Gierschner, Patrick Bühler, Ulrich Wetterauer
  • Monoclonal Antibodies and Single Chain Antibody Fragments Against Cell-Surface Prostate Specific Membrane Antigen
    Publication number: 20090041789
    Abstract: Isolated monoclonal antibodies or an antigen binding portion thereof which bind to prostate specific membrane antigen in its native form occurring on the surface of tumor cells characterized in that it is linked to a label or a cytotoxic agent or constructed as a part of a bispecific antibody or a recombinant diabody.
    Type: Application
    Filed: March 2, 2006
    Publication date: February 12, 2009
    Inventors: Ursula Elsaesser-Beile, Philipp Wolf, Dorothee Gierschner, Patrick Buehler, Ulrich Wetterauer
  • Endoscope/resectoscope and shield therefor
    Patent number: 5024212
    Abstract: An endoscope, in particular a resectoscope, for excising tissue, having a barrel insertable into a body cavity for feeding in and draining out an irrigating liquid and for carrying a working element which can be actuated from the proximal end of the endoscope and whose field of activity can be monitored visually through an endoscope telescope positioned at the proximal end of the endoscope, in which to protect a surgeon, a protective shield can be releasably secured on a lengthwise segment of the endoscope, namely on a lengthwise segment comprising those segments of the working element and of the endoscope telescope which project proximally from the barrel of the endoscope.
    Type: Grant
    Filed: April 26, 1990
    Date of Patent: June 18, 1991
    Assignee: Richard Wolf GmbH
    Inventors: Ludwig Bonnet, Ulrich Wetterauer